Skip to main content

Table 3 Comparison of 18F-FDG PET/CT and 18F-FAPI PET/CT for the extrahepatic lesions

From: Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma

Description of lesions

No. of patients (No. of lesions)

18F-FDG PET/CT

18F-FAPI PET/CT

P value

(FDG vs. FAPI)

Positive detection of lesions(%)

Median SUVmax (range)

Median TBR (range)

Positive detection of lesions(%)

Median SUVmax (range)

Median TBR (range)

SUVmax

TBR

Lymph node metastasis

7(129)

115(89.1%)

7.6(1.2–20.7)

4.5(0.5–17.3)

126(97.9%)

7.3(2.0–21.8)

6.3(1.4–26.5)

0.7475

 < 0.0001

 Head and neck regions

3(16)

13(81.3%)

4.8(1.2–14.7)

2.1(0.5–9.2)

16(100%)

7.7(3.0–13.9)

5.2(1.5–17.4)

0.0148

 < 0.0001

 Thoracic regions

2(15)

15(100%)

11.5(3.1–16.4)

7.2(1.3–10.3)

15(100%)

13.1(8.5–21.2)

16.4(4.7–26.5)

0.0267

 < 0.0001

 Abdominal regions

7(86)

81(94.2%)

7.95(1.8–20.7)

4.9(0.8–17.3)

83(96.5%)

6.9(2.0–21.8)

5.3(1.4–16.9)

0.0772

0.2818

 Pelvic regions

2(12)

6(50%)

2.8(1.7–10.6)

1.3(0.8–6.6)

12(100%)

7.1(3.0–13.8)

7.4(2.3–10.6)

0.1763

0.0005

Lymph node size(cm)

 ≤ 1

NA(65)

51(78.5%)

5.2(1.2–16.7)

3.3(0.5–13.9)

62(95.4%)

6.2(2.0–21.8)

5.0(1.4–23.1)

0.1253

0.0016

  > 1

NA(64)

64(100%)

10.55(3.1–20.7)

6.75(1.3–17.3)

64(100%)

9.35(3.1–21.2)

10.15(2.0–26.5)

0.3771

0.0004

Distant lesions

9(66)

46(69.7%)

5.0(0.7–25.4)

6.5(0.6–84.7)

42(63.6%)

2.75(0.5–20.4)

7.45(1.7–30.0)

0.0139

0.582

 Lung

6(24)

7(29.1%)

1.4(0.7–10.2)

6.5(3.5–51.0)

8(37.5%)

1.65(0.5–10.5)

13.0(1.7–28.0)

0.7196

0.0639

 Bone

3(24)

24(100%)

11.1(5.2–25.4)

24.15(2.9–84.7)

16(66.7%)

3.0(1.1–20.4)

6.3(2.8–30.0)

0.0007

0.0014

 Peritoneal

1(17)

14(82.4%)

3.9(1.3–7.7)

1.7(0.6–3.3)

17(100%)

4.8(2.3–7.0)

5.3(2.6–7.8)

0.0731

 < 0.0001

 Adrenal gland

1(1)

1(100%)

5.6(NA)

1.9(NA)

1(100%)

4.8(NA)

4.8(NA)

-

-

Total

13(195)

161(82.6%)

6.3(0.7–25.4)

5.1(0.5–84.7)

168(86.2%)

6.4(0.5–21.8)

6.6(1.4–30.0)

0.2538

0.0007

  1. Bold fonts indicate significant difference between FDG and FAPI (P < 0.05)
  2. 18F Fluorine 18, FDG fluorodeoxyglucose, FAPI fibroblast activation protein inhibitor, PET/CT positron emission tomography/computed tomography, HCC hepatocellular carcinoma, SUVmax maximum standardized uptake value, TBR Tumor-to-background ratio, NA Not applicable